A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer’s disease supports further investigation of its potential.
from Dementia Big http://ift.tt/2qDzuPh via alcoholic dementia
http://ift.tt/2sgI9bh
No comments:
Post a Comment